Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why Galera Therapeutics (GRTX) Stock Is Nosediving

Galera Therapeutics shares are trading lower by 34.8% during Monday's session. The company said its shares will be delisted due to non-compliance with Nasdaq's continued listing standards.
byHenry Khederian
June 3, 2024
1 minute read
Total
0
Shares
0
0
0
0
0
0

Galera Therapeutics Inc (NASDAQ:GRTX) shares are trading lower by 34.8% to $0.14 during Monday’s session after the company received a notice from Nasdaq’s Office of General Counsel stating that the Nasdaq Hearings Panel decided to delist the company’s shares due to non-compliance with Nasdaq’s continued listing standards.

The company failed to meet the minimum average market value of listed securities, the minimum bid price, and the minimum market value of publicly held shares. As a result, trading of the company’s shares will be suspended on Nasdaq starting June 4, 2024.

Galera Therapeutics plans for its shares to be quoted on the OTC Markets Group under the symbol “GRTX” following the suspension. The company says it retains the right to request a review of the delisting decision.

See Also: GameStop Nearly Doubles, AMC Soars 30% Premarket: What’s Setting Meme Stocks On Fire Again?

According to data from Benzinga Pro, GRTX has a 52-week high of $3.59 and a 52-week low of $0.08.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Enhabit Says After Evaluating A Full Range Of Strategic Alternatives, Including A Potential Sale, Merger Or Other Transaction, The Board Unanimously Determined That Continuing To Execute On The Company’s Strategic Plan; Commences Planned Board Transiti…

By Benzinga Newsdesk
May 8, 4:19 PM
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced Enhabit's Board of Directors (the "Board") has concluded the Company's strategic review process, announced in August 2023, which was

EHAB

Read More

Fed’s Preferred Inflation Measure Comes In Cooler Than Expected As Banking Crisis Complicates Powell’s Plan

By Wayne Duggan
March 31, 8:39 AM
The SPDR S&P 500 ETF Trust SPY (NYSE: SPY) traded higher by 0.3% on Friday morning after the Bureau of Economic Analysis reported a 5% increase in the personal consumption expenditures price index in the month of February, suggesting the Federal Reserve still has a long way to go in its

SPY